Literature DB >> 4022213

Levamisole circumvents inhibition of lymphocyte activation imposed by uremic serum.

D Modai, J Weissgarten, U Shaked, S Segal, A Pik, R Fuchs.   

Abstract

Uremic serum inhibits thymidine incorporation of phytohemagglutinin-stimulated lymphocytes originating in normal individuals. In this study the effect of levamisole on such inhibition was investigated. Preincubation with a wide range of levamisole concentrations resulted in complete prevention of the inhibitory effect imposed by uremic serum on thymidine incorporation. We would like to suggest that uremic serum possibly inhibits thymidine incorporation of normal lymphocytes by imposing an abnormal cyclic GMP/cyclic AMP intracellular ratio, and that levamisole may restore this ratio to normal.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4022213     DOI: 10.1159/000183515

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  1 in total

1.  Alteration in lymphocyte phenotype associated with administration of adjuvant levamisole and 5-fluorouracil.

Authors:  R F Holcombe; R M Stewart; K W Betzing; K Kannan
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.